ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,732.93
      0.25%
      US Tech 100
      19,414.80
      0.00%
      Dow Jones
      42,208.22
      0.20%
      Brent Oil
      74.22
      -0.46%
      Bitcoin
      63,786.86
      -0.75%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Astria Therapeutics Inc (ATXS) Quote

      Astria Therapeutics Inc

      Astria Therapeutics Inc (ATXS)

      NASDAQ
      12.50
      0.00
      (0.00%)
      Closed September 25 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      12.50
      Bid
      10.01
      Ask
      11.00
      Volume
      -
      0.00 Day's Range 0.00
      4.26 52 Week Range 16.90
      Market Cap
      705.316M
      Previous Close
      12.50
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      366,630
      Shares Outstanding
      56,425,282
      Dividend Yield
      -
      PE Ratio
      -6.61
      Earnings Per Share (EPS)
      -1.29
      Revenue
      -
      Net Profit
      -72.89M

      About Astria Therapeutics Inc

      Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.astriatx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Astria Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXS. The last closing price for Astria Therapeutics was $12.50. Over the last year, Astria Therapeutics shares have traded in a share price range of $ 4.26 to $ 16.90.

      Astria Therapeutics currently has 56,425,282 shares outstanding. The market capitalization of Astria Therapeutics is $705.32 million. Astria Therapeutics has a price to earnings ratio (PE ratio) of -6.61.

      Ask ADVFN Intelligence (AI)

      ATXS Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      19 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      19 hours ago

      Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress

      Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present...

      September 19 2024
      Business Wire

      Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 180,000...

      September 04 2024
      Business Wire

      Astria Therapeutics to Present at Upcoming Bradykinin Symposium

      Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present two...

      August 30 2024
      Business Wire

      Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference

      Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will participate...

      August 29 2024
      Business Wire

      Form S-8 - Securities to be offered to employees in employee benefit plans

      August 12 2024
      Edgar (US Regulatory)

      Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

      -- Navenibart (STAR-0215), the Potential Market-Leading Therapy for the Treatment of Hereditary Angioedema, on Track for Expected Phase 3 Initiation in Q1 2025 -- -- Preclinical Results Support...

      August 12 2024
      Business Wire

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 12 2024
      Edgar (US Regulatory)

      Astria Therapeutics Chooses Ypsomed’s YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary Angioedema

      Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it has chosen...

      August 12 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.917.8515962036211.5912.9211.3167550412.45400162CS
      40.473.9068994181212.0312.9210.26539302911.92966637CS
      123.538.8888888889912.928.8536663011.25932753CS
      26-4.25-25.373134328416.7516.98.58556634410.87686199CS
      525.6281.68604651166.8816.94.2659704910.77293624CS
      1562.7628.33675564689.7416.92.3629247310.42037436CS
      2603.9746.54161781958.5316.92.3628966610.41424793CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 11.04
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1458
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.95
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.89
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.6796
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 11.04
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1458
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.95
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.89
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.6796
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 11.04
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1458
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 63.95
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 1.89
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.6796
      (0.00%)
      		0

      ATXS Discussion

      View Posts
      Monksdream Monksdream 2 weeks ago
      ATXS under $15
      👍️0
      Monksdream Monksdream 3 months ago
      ATXS under $10
      👍️0
      Monksdream Monksdream 5 months ago
      ATXS under $10
      👍️0
      GreenStockEVs GreenStockEVs 1 year ago
      NEWS OUT - Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema

      About Astria Therapeutics:

      Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Learn more about our company on our website, www.astriatx.com.
      👍️0

      Your Recent History

      NASDAQ
      ATXS
      Astria Therapeutics
      GDAX
      ENJUSD
      Enjin Coin
      Delayed Upgrade Clock